The Changing Role of Analytical Science in Drug Discovery - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Changing Role of Analytical Science in Drug Discovery

How complex biological models, larger datasets, and laboratory automation are shaping drug discovery decisions

  • By

  • James Strachan

  • August 27, 2026

  • 3 min

Share

Clinical Report: The Changing Role of Analytical Science in Drug Discovery

Overview

Analytical science is evolving in drug discovery, with advancements in data generation and automation. The integration of more physiologically relevant models presents challenges in data consistency and reproducibility.

Background

The role of analytical science in drug discovery is critical as it underpins the development of novel therapeutics and informs regulatory decisions. The increasing complexity of biological models introduces challenges in data reliability.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • Analytical science is generating richer datasets that inform earlier decision-making in drug discovery.
  • Automation improves consistency in handling complex biological models.
  • Complex models introduce challenges in data reproducibility.
  • Advancements in analytical technologies enhance the reliability of data generated from biological systems.
  • AI and automated workflows enable the evaluation of more conditions and larger datasets.

Clinical Implications

Automation can help manage variability in drug discovery.

Conclusion

The changing landscape of analytical science in drug discovery highlights the need for advancements in automation and data analysis.

Related Resources & Content

  1. Farley M. M., SLAS, 2023 -- The Changing Role of Analytical Science in Drug Discovery
  2. the analytical scientist — Around the World in 80 Assays
  3. the analytical scientist — What is the Point of Analytical Science?
  4. the analytical scientist — Why Start-ups Need Analytical Science
  5. ICH M15 Guideline
  6. Bioanalytical Method Validation for Biomarkers | FDA
  7. ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - PubMed
  8. Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial - PubMed
  9. FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program | FDA
  10. Introduction to the 3RsC's cross-platform microphysiological systems evaluation for drug-induced liver injury in collaboration with FDA-CDER - PubMed
  11. Assay Guidance Manual Program

Original Source(s)

The Changing Role of Analytical Science in Drug Discovery

  • by James Strachan

  • August 27, 2026

Related Content

Tissue Clocks Link Aging With Disease

Models trained on histology images detected aging patterns in the brain, gastrointestinal tract, and other organs

  • August 26, 2026

  • 3 min
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML

New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a difficult-to-treat form of acute myeloid leukemia (AML).

  • by

  • August 26, 2026

  • 3 min
Fatal Police Pursuits and Neighborhood Opportunity—Interpreting and Acting on a Concentrated Harm